findmyKOL
Clinical trialNCT05603078RecruitingInterventional

A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)

SponsorCancer Institute and Hospital, Chinese Academy of Medical SciencesEnrollment102Breast Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Hao Jing, M.D.

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Principal Investigator
  • Jing Wang, M.D.

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Study Chair
  • Shu-lian Wang, M.D.

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Study Chair
  • Xiang-yi Kong, M.D.

    Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • National Cancer Center/national Clinical Research Center for Cancer/cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    Beijing, Beijing Municipality, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Jun 2022
Primary completion
19 Jul 2026
Completion
31 Jul 2028
Last update posted
2 Nov 2022
Registered enrollment
102
Registry id
NCT05603078

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.